Treatment of Sarcoidosis

被引：41
作者：
Wijsenbeek, Marlies S. [1 ]
Culver, Daniel A. [2 ,3 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Pulm Med, NL-3015 CE Rotterdam, Netherlands
[2] Cleveland Clin, Resp Inst, Dept Pulm Med, Cleveland, OH 44195 USA
[3] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA
来源：
CLINICS IN CHEST MEDICINE | 2015年 / 36卷 / 04期
关键词：
Sarcoidosis; Treatment; Corticosteroids; Steroid sparing; TNF antagonists; Prognosis; Patient preferences; QUALITY-OF-LIFE; CHRONIC PULMONARY SARCOIDOSIS; ACTIVE RHEUMATOID-ARTHRITIS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; CORTICOSTEROID-THERAPY; MYCOPHENOLATE-MOFETIL; CARDIAC SARCOIDOSIS; INTRATHORACIC SARCOIDOSIS; PERIPHERAL NEUROPATHY;
D O I：
10.1016/j.ccm.2015.08.015
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Treatment of sarcoidosis is not required in all patients with the diagnosis. The decision to treat and the strategy for how to treat usually require input and shared decision making by the patient. Some common consequences of sarcoidosis are not caused by granulomatous inflammation, but may be the dominant disease manifestation and should be actively considered when formulating a treatment plan. The medication regimen should be tailored to each patient. Steroid-sparing medications should be prescribed early as part of a long-term strategy.
引用
收藏
页码：751 / +
页数：18
相关论文
共 202 条
[71]  
Food and Drug Administration, 2005, LAB INF LEFL
[72]   Morbidity and mortality in sarcoidosis [J].
Gerke, Alicia K. .
CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) :472-478
[73]   British Thoracic Society Sarcoidosis study: Effects of long term corticosteroid treatment [J].
Gibson, GJ ;
Prescott, RJ ;
Muers, MF ;
Middleton, WG ;
Mitchell, DN ;
Connolly, CK ;
Harrison, BDW .
THORAX, 1996, 51 (03) :238-247
[74]   RATE OF IMPROVEMENT OF PULMONARY-FUNCTION IN SARCOIDOSIS DURING TREATMENT WITH CORTICOSTEROIDS [J].
GOLDSTEIN, DS ;
WILLIAMS, MH .
THORAX, 1986, 41 (06) :473-474
[75]  
GOLDSZER RC, 1981, ARCH PATHOL LAB MED, V105, P478
[76]   Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients [J].
Gonnelli, S ;
Rottoli, P ;
Cepollaro, C ;
Pondrelli, C ;
Cappiello, V ;
Vagliasindi, M ;
Gennari, C .
CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (05) :382-385
[77]   Outcome in sarcoidosis - The relationship of relapse to corticosteroid therapy [J].
Gottlieb, JE ;
Israel, HL ;
Steiner, RM ;
Triolo, J ;
Patrick, H .
CHEST, 1997, 111 (03) :623-631
[78]   Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK [J].
Gribbin, J. ;
Hubbard, R. B. ;
Le Jeune, I. ;
Smith, C. J. P. ;
West, J. ;
Tata, L. J. .
THORAX, 2006, 61 (11) :980-985
[79]  
Grunewald J, 2012, EXPERT REV CLIN IMMU, V8, P55, DOI [10.1586/ECI.11.76, 10.1586/eci.11.76]
[80]   Lofgren's Syndrome Human Leukocyte Antigen Strongly Influences the Disease Course [J].
Grunewald, Johan ;
Eklund, Anders .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (04) :307-312
3456789101112